Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Tsuyoshi Yoshimoto"'
Autor:
Rie, Sugimoto, Kenta, Motomura, Aritsune, Ooho, Yoshifusa, Aratake, Akihiro, Ueda, Takeshi, Senju, Yuki, Tanaka, Masayoshi, Yada, Kohsuke, Tanaka, Akifumi, Kuwano, Yuusuke, Morita, Shigehiro, Nagasawa, Mari, Ooe, Taiji, Mutsuki, Tsuyoshi, Yoshimoto, Naoki, Yamashita, Mai, Nakashima, Tomonobu, Hioki, Toshimasa, Koyanagi, Nobito, Higuchi, Tsukasa, Nakamura, Shigeru, Harada, Masatake, Tanaka, Seiya, Tada, Takeaki, Satoh, Koutarou, Uchimura, Masami, Kuniyoshi, Makoto, Nakamuta, Motoyuki, Kohjima
Publikováno v:
Internal medicine (Tokyo, Japan). 61(21)
Objective Multiple therapeutic agents exist for advanced hepatocellular carcinoma (HCC), but prognostic factors in second-line and subsequent therapies are unclear. Ramucirumab is a molecular-targeted agent effective against hepatocytes with alpha-fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83d1428c27ff83c2a8c203f8e7e194f5
https://pubmed.ncbi.nlm.nih.gov/36328582
https://pubmed.ncbi.nlm.nih.gov/36328582
Autor:
Rie, Sugimoto, Takeaki, Satoh, Akihiro, Ueda, Takeshi, Senju, Yuki, Tanaka, Shinsaku, Yamashita, Toshimasa, Koyanagi, Tomoyuki, Kurashige, Nobito, Higuchi, Tsukasa, Nakamura, Masatake, Tanaka, Yuuki, Azuma, Akari, Ohno, Aritsune, Ooho, Mari, Ooe, Taiji, Mutsuki, Koutarou, Uchimura, Masami, Kuniyoshi, Seiya, Tada, Yoshifusa, Aratake, Tsuyoshi, Yoshimoto, Naoki, Yamashita, Shigeru, Harada, Makoto, Nakamuta, Kenta, Motomura, Motoyuki, Kohjima
Publikováno v:
Medicine. 101(40)
To evaluate the efficacy of atezolizumab plus bevacizumab treatment in patients with hepatocellular carcinoma (HCC) previously treated with molecular targeted agents (MTAs). Thirty-one patients treated with atezolizumab plus bevacizumab for unresecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7efa2a21531e82db0e1520d014bcf0eb
https://pubmed.ncbi.nlm.nih.gov/36221372
https://pubmed.ncbi.nlm.nih.gov/36221372
Autor:
Hirotaka, Tsuru, Keishi, Komori, Masafumi, Wada, Youichiro, Iboshi, Yorinobu, Sumida, Tsuyoshi, Yoshimoto, Eikichi, Ihara, Naohiko, Harada, Makoto, Nakamuta, Yoshihiro, Ogawa
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 117(10)
A 76-year-old woman suffered from repeated postprandial syncope of unknown cause. Computed tomography scanning revealed an enlarged hiatal hernia sac with food residues that compressed both the left atrium and inferior vena cava. As soon as the herni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2c1a9dce7958eee971a43716e9d06778
https://pubmed.ncbi.nlm.nih.gov/33041302
https://pubmed.ncbi.nlm.nih.gov/33041302
Autor:
Keisuke Yoshino, Kazuhiro Iwasaki, Koji Nakamura, Tsuyoshi Yoshimoto, Arisa Yamashita, Yukie Kanazawa, Yoshihiko Abe, Kaori Funatsu, Shigeru Suzuki
Publikováno v:
Journal of Pharmaceutical Sciences
The functionality of a newly developed silicone oil-free (SOF) syringe system, of which the plunger stopper is coated by a novel coating technology (i-coating™), was assessed. By scanning electron microscopy observations and other analysis, it was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b65aa7a1b5d4aa2ff8fe9893301ec29e
Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism
Autor:
Masaki Kato, Atsushi Nakajima, Yuichi Nozaki, Tsukasa Nakamura, Kunitaka Fukuizumi, Kazuhiro Kotoh, Ryoko Yada, Makoto Nakamuta, Yoshihiko Maehara, Motoyuki Kohjima, Yusuke Murata, Ken Shirabe, Akira Honda, Nobuyoshi Fukushima, Tsuyoshi Yoshimoto, Munechika Enjoji, Manabu Nakashima, Yasushi Matsuzaki
Publikováno v:
Liver International. 35:1095-1102
Background & Aims Injury to biliary epithelial cells caused by disorders in bile composition may be the initial step in the pathogenesis of primary biliary cirrhosis (PBC). We therefore examined choline/phospholipid metabolism in livers of patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67dad025a14bc202fbd920c162e45284
https://doi.org/10.1111/liv.12526
https://doi.org/10.1111/liv.12526
Autor:
Munechika Enjoji, Makoto Nakamuta, Tsuyoshi Yoshimoto, Yusuke Murata, Kazuhisa Matsunaga, Miho Kurokawa, Masaki Kato, Naohiko Harada, Tomoko Ohashi, Kunitaka Fukuizumi, Tsukasa Nakamura, Kazuhiro Kotoh, Motoyuki Kohjima
Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7347d79eb1fc2814f27980965573f43e
https://europepmc.org/articles/PMC4840744/
https://europepmc.org/articles/PMC4840744/
Autor:
Yasuhito Tanaka, Kazuhiro Kotoh, Makoto Nakamuta, Tsuyoshi Yoshimoto, Motoyuki Kohjima, Munechika Enjoji, Kunitaka Fukuizumi, Yoko Aoyagi, Manabu Nakashima, Naoya Sakamoto, Tatsuya Fujino, Masayoshi Yada, Masaki Kato, Naohiko Harada, Nobuyoshi Fukushima, Ryoko Yada
Publikováno v:
Journal of Medical Virology. 85:250-260
Despite the use of pegylated-interferon (peg-IFN) plus ribavirin combination therapy, many patients infected with hepatitis C virus (HCV)-1b remain HCV-positive. To determine whether addition of pitavastatin and eicosapentaenoic acid (EPA) is benefic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c442829c2f292f1f0fbd73fbf0d8ce
https://doi.org/10.1002/jmv.23464
https://doi.org/10.1002/jmv.23464
Autor:
Yoriko Ura, Naohiko Harada, Tsuyoshi Yoshimoto, Shuji Matsuura, Hirofumi Ikeda, Masaru Nakayama, Kanako Nishida, Kazuhiko Tsuruya
Publikováno v:
Nihon Toseki Igakkai Zasshi. 45:651-656
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e54417e9809199b910207ab0b28af4
https://doi.org/10.4009/jsdt.45.651
https://doi.org/10.4009/jsdt.45.651
Autor:
Munechika Enjoji, Y. Maehara, Tsuyoshi Yoshimoto, Naohiko Harada, Yoko Aoyagi, Manabu Nakashima, Kazuhiro Kotoh, Motoyuki Kohjima, Masaki Kato, Ryoko Yada, Kunitaka Fukuizumi, Akinobu Taketomi, Masayoshi Yada, M. Nakamuta, Tatsuya Fujino, Kenichiro Yasutake
Publikováno v:
Journal of Medical Virology. 83:921-927
Recent studies have demonstrated that several cellular factors are involved in entry of hepatitis C virus (HCV) into host cells. Detailed gene expression profiles of these factors in HCV-infected livers have not been reported for humans. Transcriptio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58005bd433f561b9296314868b59fa84
https://doi.org/10.1002/jmv.22042
https://doi.org/10.1002/jmv.22042
Autor:
Masayoshi Yada, Makoto Nakamuta, Nobito Higuchi, Munechika Enjoji, Tatsuya Fujino, Akinobu Taketomi, Kazuhiro Kotoh, Motoyuki Kohjima, Ryoko Yada, Masaki Kato, Naohiko Harada, Yoshihiko Maehara, Tsuyoshi Yoshimoto, Manabu Nakashima
Publikováno v:
Hepatology International. 3:490-496
Because dyslipidemia, such as hypercholesterolemia, is a characteristic of primary biliary cirrhosis (PBC), hepatic lipid metabolism may be disturbed in PBC patients. We examined the expression of lipid metabolism-associated genes in PBC liver.All of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfec4d11d56308f4735adcb84f123512
https://doi.org/10.1007/s12072-009-9137-y
https://doi.org/10.1007/s12072-009-9137-y